Cancer News and Research

Latest Cancer News and Research

Exposure of expectant mothers to urban air pollution may alter the structure of babies' chromosomes while in the womb

A new study of 60 newborns in New York City reveals that exposure of expectant mothers to combustion-related urban air pollution may alter the structure of babies' chromosomes while in the womb.

15 Feb 2005

Claims about the experimental protein-based assay are not biologically plausible

In a new study, researchers present a "cautionary tale" about what may go wrong when using the fledgling science of proteomics to devise a diagnostic test for cancer.

15 Feb 2005

Vioxx doubles risk of heart attacks and strokes

The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.

15 Feb 2005

Achieva 3T MR Scanner launched officially launched

The first 'next generation' MRI (magnetic resonance imaging) body scanner in the world will be officially launched at Hope Hospital later this week (Friday 18th February).

15 Feb 2005

More dependable, less expensive tool to help detect bladder cancer earlier

Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can be administered and read in the doctor's office was three times more effective than a conventional laboratory test for detecting bladder cancer.

15 Feb 2005

Blocking estrogen may be vitally important to improving survival from lung cancer

New and effective treatments for lung cancer may rest on their ability to hinder the action of estrogen in lung cancer cells, according to two studies published in the current issue of Cancer Research.

15 Feb 2005

Green tea extract has potential as an anti-cancer agent

A new study on bladder cancer cells lines shows that green tea extract has potential as an anti-cancer agent, proving for the first time that it is able to target cancer cells while leaving healthy cells alone.

15 Feb 2005

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B Virus (HBV), an acute sometimes fatal form of viral hepatitis caused by a DNA virus that persists in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids.

14 Feb 2005

Mesoblast signs adult stem cells agreement

Australia’s adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.

14 Feb 2005

New compound AMN107 may help treat some imatinib resistant cancer cases

As scientists uncover the precise molecular mechanisms that underlie effective cancer treatments, they gain invaluable insight into why predominantly successful treatments fail for some patients.

14 Feb 2005

Under-active thyroid associated with reduced breast cancer risk

Researchers at The University of Texas M. D. Anderson Cancer Center have found that women with a common thyroid gland disorder appear to have a reduced chance of developing invasive breast cancer, according to a study published in the March 15 issue of Cancer, out online Feb. 14.

14 Feb 2005

Medical expenditures for morbidly obese adults far outweighs that for normal-weight adults

Health-care costs for morbidly obese adults are nearly twice those of people considered to be of normal weight, says a study led by University of Cincinnati (UC) researchers.

14 Feb 2005

Bionomics goes for aggressive strategy in 2005

Australian biotech, Bionomics gave an investor presentation in Melbourne on 2 February 2005 and outlined a bolder, more aggressive strategy. There are many Australian biotech companies with big aspirations.

13 Feb 2005

Why estrogenic hormones produce unintended results in women

New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.

13 Feb 2005

Two-step approach to transform HIV into a cancer-seeking machine

Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine.

13 Feb 2005

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.

10 Feb 2005

Expanded HIV screening can increase patient life span

Expanded HIV screening can increase patient life span, prevent the spread of the disease, and is cost effective, researchers at Yale, Harvard and the Massachusetts General Hospital report in the February 10 issue of the New England Journal of Medicine (NEJM).

10 Feb 2005

Chronic nicotine exposure worsens some Alzheimer’s-related brain abnormalities

UCI researchers have determined that chronic nicotine exposure worsens some Alzheimer’s-related brain abnormalities, contradicting the common belief that nicotine can actually be used to treat the disease.

9 Feb 2005

Artemisinin could selectively kill cancer cells while leaving normal cells unharmed

Researchers at the University of Washington have blended the past with the present in the fight against cancer, synthesizing a promising new compound from an ancient Chinese remedy that uses cancer cells' rapacious appetite for iron to make them a target.

9 Feb 2005

Patients with cancer have a 7-fold increased risk for blood clots in the legs or lungs

Studies that identify patients at highest risk of thrombosis are scarce, according to background information in the article. It is unclear what risks are for various types and stages of cancer.

9 Feb 2005

Cancer News and Research

Latest Cancer News and Research

Exposure of expectant mothers to urban air pollution may alter the structure of babies' chromosomes while in the womb

Claims about the experimental protein-based assay are not biologically plausible

Vioxx doubles risk of heart attacks and strokes

Achieva 3T MR Scanner launched officially launched

More dependable, less expensive tool to help detect bladder cancer earlier

Blocking estrogen may be vitally important to improving survival from lung cancer

Green tea extract has potential as an anti-cancer agent

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Mesoblast signs adult stem cells agreement

New compound AMN107 may help treat some imatinib resistant cancer cases

Under-active thyroid associated with reduced breast cancer risk

Medical expenditures for morbidly obese adults far outweighs that for normal-weight adults

Bionomics goes for aggressive strategy in 2005

Why estrogenic hormones produce unintended results in women

Two-step approach to transform HIV into a cancer-seeking machine

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Expanded HIV screening can increase patient life span

Chronic nicotine exposure worsens some Alzheimer’s-related brain abnormalities

Artemisinin could selectively kill cancer cells while leaving normal cells unharmed

Patients with cancer have a 7-fold increased risk for blood clots in the legs or lungs

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in